Quality of Life of Patients with Head and Neck Cancer Receiving Cetuximab, Fluorouracil, Cisplatin Comparing to Cetuximab, Fluorouracil, Cisplatin, and Docetaxel within the CEFCID Trial.
Goerling U, Gauler T, Dietz A, Grünwald V, Knipping S, Guntinas-Lichius O, Frickhofen N, Lindeman HW, Fietkau R, Haxel B, Große-Thie C, Maschmeyer G, Zipfel M, Martus P, Knoedler M, Keilholz U, Klinghammer K.
Goerling U, et al. Among authors: knipping s.
Oncol Res Treat. 2022;45(6):319-325. doi: 10.1159/000521415. Epub 2021 Dec 10.
Oncol Res Treat. 2022.
PMID: 34915492
Clinical Trial.